What Is 7Tabz? 7-OH Tablets Explained and What Changes August 5

7Tabz is a brand of pressed 7-hydroxymitragynine tablets sold through smoke shops and online kratom retailers. With the Drug Enforcement Administration's temporary scheduling order due on or after August 5, 2026, a lot of people are looking up what they have been buying. This guide covers what 7Tabz products are, what strengths the brand publishes, and how the federal action applies to concentrated 7-OH tablets generally.

Our own shop sells Cat's Claw botanicals rather than kratom products, which is worth stating plainly. What follows is drawn from published retail specifications and from the text of the federal notices. Nothing here is an allegation against 7Tabz, which is an operating brand in a category that has been legal to sell.

What 7Tabz Products Are

7Tabz makes pressed tablets whose labeled active ingredient is 7-hydroxymitragynine, usually written as 7-OH. It is a minor alkaloid that occurs in kratom leaf (Mitragyna speciosa) at trace concentrations — far too little to press into a tablet at the strengths this category is built around. Concentrated products therefore use extracted or converted material rather than leaf.

The brand's positioning in the market is built around fixed-dose convenience: a tablet carries a stated milligram amount, which is easier to track than loose powder measured by scoop or scale. The tablets are sold as chewable or swallowable depending on the line, and are flavored, largely because concentrated botanical material is bitter and a chewable format needs a flavor system to be workable at all.

Published Product Specifications

7Tabz spans a wide potency range across several named tiers. The table reflects specifications published by retailers at the time of writing.

Flavor names reported across listings include berry, blue razz, tangerine and other citrus profiles, plus an unflavored option in the Max Potency line. Availability rotates. We were not able to verify per-tablet milligram figures or pack counts for the dual-alkaloid blend and liquid shot lines from published listings, so those are marked as varying by product rather than filled in with a guess.

Reading Milligram Figures Carefully

One recurring source of confusion in this category is the difference between a per-tablet number and a pack total. A listing headlined with a large milligram figure may be describing the whole blister pack — four 65mg tablets advertised as "260mg," for instance. Neither presentation is wrong, but they are not comparable to each other, and a shopper comparing headline numbers across brands can easily end up comparing a tablet to a package.

A second point worth understanding: 7-OH tablet strengths are stated as an isolated compound. That is different from products built on undisclosed proprietary blends, where a milligram figure refers to a total extract mass rather than to any single named substance. When you compare products, check which kind of number you are looking at.

What the DEA Action Says

On July 1, 2026, the DEA filed Notices of Intent to temporarily place 7-hydroxymitragynine above a specified threshold into Schedule I of the Controlled Substances Act. A companion notice covers mitragynine pseudoindoxyl, MGM-15, and MGM-16. Both published in the Federal Register on July 6, 2026. The agency's announcement is available at dea.gov.

The essentials:

• Earliest order date: the temporary scheduling order will not issue before August 5, 2026.
• Duration: two years, during which the DEA can pursue permanent scheduling.
• Threshold for leaf material: 0.05% 7-OH.
• Threshold for extracts, concentrates, edibles, and pressed pills: 0.05% or 1mg per article.

The phrase per article is what makes this concrete for tablets. A single pressed tablet is an article. A 15mg tablet — the lowest strength 7Tabz publishes — carries fifteen times the 1mg threshold. A 135mg tablet carries one hundred thirty-five times it. There is no strength in this product category, or in any competing concentrated 7-OH tablet line, that comes anywhere near being under the limit.

That is the design of the threshold rather than an accident. It was set low enough that natural leaf material does not reach it and high enough that the action targets concentrated and enhanced products specifically. Our full walkthrough is in the 7-OH threshold explained, and the practical version of the question is answered in is 7-OH banned.

What Changes on or After August 5

When a temporary scheduling order issues, Schedule I controls attach to the covered substances. That reaches manufacturing, distribution, import, export, and research involving material above the threshold. Schedule I registration requirements are not something a general retail supply chain is set up to meet.

Points worth keeping straight:

• This is a federal action with nationwide reach, not a state-level rule. State kratom laws still exist and still differ, but they sit alongside this rather than replacing it.
• It applies by concentration and quantity, not by brand name. No brand in this category is treated differently from another under the threshold.
• August 5, 2026 is the earliest date the order can issue, not a confirmed effective date. The actual date depends on publication.
• "Temporary" here means two years, with a path to permanent scheduling — not a brief pause.

We want to be clear about what we are and are not saying. We are describing a published federal action and the published specifications of a product line. We are not accusing 7Tabz of anything, and we are not telling you what is or is not legal in your particular situation — that is a question for a qualified attorney.

Looking at kratom-free options?

With the August date approaching, many consumers are exploring what else is available on the botanical shelf. There are products that contain no kratom and no 7-OH whatsoever — entirely different plants, with their own alkaloid profiles and their own regulatory standing. Cat's Claw (Uncaria tomentosa), a vine native to the Amazon basin, is one of them, and it is the botanical our shop is built around.

We are not going to characterize these as replacements or describe what they do. They are separate botanicals that deserve to be evaluated on their own merits. If you want background first, there is a plain-language primer at what is Cat's Claw, batch testing documentation at our COA page, and the products themselves in the Cat's Claw collection.

Frequently Asked Questions

What strengths does 7Tabz come in?

Published per-tablet figures include 15mg (Pure), 30mg (Ultra Potent), 65mg (Max Potency), and 135mg (Ultra Strength). The brand also references dual-alkaloid blends and liquid extract shots, for which we could not verify specific per-unit figures.

What is the difference between 7-OH and mitragynine?

Both are alkaloids associated with the kratom plant. Mitragynine is the primary and most abundant alkaloid in the leaf. 7-hydroxymitragynine is a minor one, present naturally at trace levels. The DEA's July 2026 notices address 7-OH above a threshold and several related compounds; they are not written around mitragynine itself.

Are 7Tabz above the DEA threshold?

The threshold for pressed pills is 0.05% or 1mg per article. Every published 7Tabz tablet strength, starting at 15mg, is substantially above 1mg per tablet — as is every concentrated 7-OH tablet we are aware of from any brand.

Will this affect products bought before August 5?

The notices govern manufacturing, distribution, and related activities from the point the order issues. Questions about anything already purchased are legal questions specific to your circumstances and jurisdiction, and we are not in a position to answer them. Consult a qualified attorney.

Is 7-OH the same as kratom leaf?

No. Kratom leaf is plant material containing many alkaloids, with 7-OH present only in trace amounts. Concentrated 7-OH products are made from extracted or converted material and contain the compound at levels leaf does not reach naturally.

These statements have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For adults 21+. Consult a qualified healthcare professional before use.